Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles M Perou

Showing results (381-390 of 447) with videos related to

Pageof 45
Sort By:
NPJ Breast Cancer|July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
Cancer Treatment Reviews|January 31, 2020
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisFrancesco Schettini, Tomás Pascual, Benedetta Conte, et al.
Cancer Research|March 3, 2017
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast CancerJuan M Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván, et al.
Nature|July 9, 2015
Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
The Journal of Clinical Investigation|June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic diseaseSusana Garcia-Recio, Aatish Thennavan, Michael P East, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2020
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast CancerErika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, et al.
Breast Cancer Research and Treatment|February 21, 2013
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancerMiguel Martín, Aleix Prat, Alvaro Rodríguez-Lescure, et al.
The Journal of Clinical Investigation|June 8, 2021
FOXA1 overexpression suppresses interferon signaling and immune response in cancerYundong He, Liguo Wang, Ting Wei, et al.
Cancer Discovery|January 22, 2017
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb ComplexJon S Zawistowski, Samantha M Bevill, Daniel R Goulet, et al.
Genome Biology|May 12, 2007
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsJason I Herschkowitz, Karl Simin, Victor J Weigman, et al.
Pageof 45

Showing results (381-390 of 447) with videos related to

Sort By:
Pageof 45
NPJ Breast Cancer|July 11, 2017
PAM50 gene signatures and breast cancer prognosis with adjuvant anthracycline- and taxane-based chemotherapy: correlative analysis of C9741 (Alliance)Minetta C Liu, Brandelyn N Pitcher, Elaine R Mardis, et al.
Cancer Treatment Reviews|January 31, 2020
HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysisFrancesco Schettini, Tomás Pascual, Benedetta Conte, et al.
Cancer Research|March 3, 2017
Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast CancerJuan M Cejalvo, Eduardo Martínez de Dueñas, Patricia Galván, et al.
Nature|July 9, 2015
Progesterone receptor modulates ERα action in breast cancerHisham Mohammed, I Alasdair Russell, Rory Stark, et al.
The Journal of Clinical Investigation|June 24, 2020
FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic diseaseSusana Garcia-Recio, Aatish Thennavan, Michael P East, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 2020
Stimulation of Oncogene-Specific Tumor-Infiltrating T Cells through Combined Vaccine and αPD-1 Enable Sustained Antitumor Responses against Established HER2 Breast CancerErika J Crosby, Chaitanya R Acharya, Anthony-Fayez Haddad, et al.
Breast Cancer Research and Treatment|February 21, 2013
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancerMiguel Martín, Aleix Prat, Alvaro Rodríguez-Lescure, et al.
The Journal of Clinical Investigation|June 8, 2021
FOXA1 overexpression suppresses interferon signaling and immune response in cancerYundong He, Liguo Wang, Ting Wei, et al.
Cancer Discovery|January 22, 2017
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb ComplexJon S Zawistowski, Samantha M Bevill, Daniel R Goulet, et al.
Genome Biology|May 12, 2007
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumorsJason I Herschkowitz, Karl Simin, Victor J Weigman, et al.
Pageof 45